Percutaneous mitral valve replacement using a transvenous, transseptal approach: Transvenous mitral valve replacement

Megan Coylewright, Allison K. Cabalka, Joseph A. Malouf, Jeffrey B. Geske, Peter M. Pollak, Rakesh M. Suri, Charanjit S. Rihal

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Objectives The aim of this paper is to describe the feasibility of a novel transcatheter approach for mitral valve replacement using only venous access. Background Failure of mitral valve prostheses necessitating reoperation can represent a high-risk clinical scenario. Although repeat cardiac surgery remains the standard of care for most failed mitral valve operations, nascent transcatheter options are under development for patients at high or extremely risk of surgery. Most often, this is performed via a transapical approach in the operating room, with associated risk of complications as well as extended length of hospital stay. Methods We describe a case series of 4 consecutive patients at high risk of reoperation with degenerative mitral prostheses (bioprosthetic valves or rings) who successfully underwent transvenous, transseptal mitral valve replacement with a commercially available transcatheter heart valve. Results From April to May 2014, 4 consecutive patients underwent transvenous, transseptal mitral valve replacement with a transcatheter heart valve. The mean age was 72 ± 9.9 years, and the average Society of Thoracic Surgeons risk score was 12.5 ± 7.2%. All patients had severe, life-limiting dyspnea. The 4 procedures were successful without intra- or post-procedural complications; echocardiography indicated a well-seated and functioning mitral valve-in-valve or valve-in-ring. Patients were discharged within 2 days after valve replacement with marked improvement in dyspnea. Conclusions We describe an innovative technique of transcatheter mitral valve replacement. This case series demonstrates the feasibility of transcatheter mitral valve replacement using only femoral venous access, with a marked reduction in complications and length of hospital stay compared with transapical access or redo surgery.

Original languageEnglish (US)
Pages (from-to)850-857
Number of pages8
JournalJACC: Cardiovascular Interventions
Volume8
Issue number6
DOIs
StatePublished - May 1 2015

Fingerprint

Mitral Valve
Length of Stay
Reoperation
Heart Valves
Dyspnea
Prostheses and Implants
Operating Rooms
Standard of Care
Thigh
Thoracic Surgery
Echocardiography

Keywords

  • degenerative mitral prosthesis
  • percutaneous mitral intervention
  • percutaneous mitral repair
  • transcatheter mitral valve replacement
  • transcatheter valve-in-ring procedure
  • transcatheter valve-in-valve procedure

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Coylewright, M., Cabalka, A. K., Malouf, J. A., Geske, J. B., Pollak, P. M., Suri, R. M., & Rihal, C. S. (2015). Percutaneous mitral valve replacement using a transvenous, transseptal approach: Transvenous mitral valve replacement. JACC: Cardiovascular Interventions, 8(6), 850-857. https://doi.org/10.1016/j.jcin.2015.01.028

Percutaneous mitral valve replacement using a transvenous, transseptal approach : Transvenous mitral valve replacement. / Coylewright, Megan; Cabalka, Allison K.; Malouf, Joseph A.; Geske, Jeffrey B.; Pollak, Peter M.; Suri, Rakesh M.; Rihal, Charanjit S.

In: JACC: Cardiovascular Interventions, Vol. 8, No. 6, 01.05.2015, p. 850-857.

Research output: Contribution to journalArticle

Coylewright, Megan ; Cabalka, Allison K. ; Malouf, Joseph A. ; Geske, Jeffrey B. ; Pollak, Peter M. ; Suri, Rakesh M. ; Rihal, Charanjit S. / Percutaneous mitral valve replacement using a transvenous, transseptal approach : Transvenous mitral valve replacement. In: JACC: Cardiovascular Interventions. 2015 ; Vol. 8, No. 6. pp. 850-857.
@article{a914670c5d69499bbbc6c3cc01c063b0,
title = "Percutaneous mitral valve replacement using a transvenous, transseptal approach: Transvenous mitral valve replacement",
abstract = "Objectives The aim of this paper is to describe the feasibility of a novel transcatheter approach for mitral valve replacement using only venous access. Background Failure of mitral valve prostheses necessitating reoperation can represent a high-risk clinical scenario. Although repeat cardiac surgery remains the standard of care for most failed mitral valve operations, nascent transcatheter options are under development for patients at high or extremely risk of surgery. Most often, this is performed via a transapical approach in the operating room, with associated risk of complications as well as extended length of hospital stay. Methods We describe a case series of 4 consecutive patients at high risk of reoperation with degenerative mitral prostheses (bioprosthetic valves or rings) who successfully underwent transvenous, transseptal mitral valve replacement with a commercially available transcatheter heart valve. Results From April to May 2014, 4 consecutive patients underwent transvenous, transseptal mitral valve replacement with a transcatheter heart valve. The mean age was 72 ± 9.9 years, and the average Society of Thoracic Surgeons risk score was 12.5 ± 7.2{\%}. All patients had severe, life-limiting dyspnea. The 4 procedures were successful without intra- or post-procedural complications; echocardiography indicated a well-seated and functioning mitral valve-in-valve or valve-in-ring. Patients were discharged within 2 days after valve replacement with marked improvement in dyspnea. Conclusions We describe an innovative technique of transcatheter mitral valve replacement. This case series demonstrates the feasibility of transcatheter mitral valve replacement using only femoral venous access, with a marked reduction in complications and length of hospital stay compared with transapical access or redo surgery.",
keywords = "degenerative mitral prosthesis, percutaneous mitral intervention, percutaneous mitral repair, transcatheter mitral valve replacement, transcatheter valve-in-ring procedure, transcatheter valve-in-valve procedure",
author = "Megan Coylewright and Cabalka, {Allison K.} and Malouf, {Joseph A.} and Geske, {Jeffrey B.} and Pollak, {Peter M.} and Suri, {Rakesh M.} and Rihal, {Charanjit S.}",
year = "2015",
month = "5",
day = "1",
doi = "10.1016/j.jcin.2015.01.028",
language = "English (US)",
volume = "8",
pages = "850--857",
journal = "JACC: Cardiovascular Interventions",
issn = "1936-8798",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Percutaneous mitral valve replacement using a transvenous, transseptal approach

T2 - Transvenous mitral valve replacement

AU - Coylewright, Megan

AU - Cabalka, Allison K.

AU - Malouf, Joseph A.

AU - Geske, Jeffrey B.

AU - Pollak, Peter M.

AU - Suri, Rakesh M.

AU - Rihal, Charanjit S.

PY - 2015/5/1

Y1 - 2015/5/1

N2 - Objectives The aim of this paper is to describe the feasibility of a novel transcatheter approach for mitral valve replacement using only venous access. Background Failure of mitral valve prostheses necessitating reoperation can represent a high-risk clinical scenario. Although repeat cardiac surgery remains the standard of care for most failed mitral valve operations, nascent transcatheter options are under development for patients at high or extremely risk of surgery. Most often, this is performed via a transapical approach in the operating room, with associated risk of complications as well as extended length of hospital stay. Methods We describe a case series of 4 consecutive patients at high risk of reoperation with degenerative mitral prostheses (bioprosthetic valves or rings) who successfully underwent transvenous, transseptal mitral valve replacement with a commercially available transcatheter heart valve. Results From April to May 2014, 4 consecutive patients underwent transvenous, transseptal mitral valve replacement with a transcatheter heart valve. The mean age was 72 ± 9.9 years, and the average Society of Thoracic Surgeons risk score was 12.5 ± 7.2%. All patients had severe, life-limiting dyspnea. The 4 procedures were successful without intra- or post-procedural complications; echocardiography indicated a well-seated and functioning mitral valve-in-valve or valve-in-ring. Patients were discharged within 2 days after valve replacement with marked improvement in dyspnea. Conclusions We describe an innovative technique of transcatheter mitral valve replacement. This case series demonstrates the feasibility of transcatheter mitral valve replacement using only femoral venous access, with a marked reduction in complications and length of hospital stay compared with transapical access or redo surgery.

AB - Objectives The aim of this paper is to describe the feasibility of a novel transcatheter approach for mitral valve replacement using only venous access. Background Failure of mitral valve prostheses necessitating reoperation can represent a high-risk clinical scenario. Although repeat cardiac surgery remains the standard of care for most failed mitral valve operations, nascent transcatheter options are under development for patients at high or extremely risk of surgery. Most often, this is performed via a transapical approach in the operating room, with associated risk of complications as well as extended length of hospital stay. Methods We describe a case series of 4 consecutive patients at high risk of reoperation with degenerative mitral prostheses (bioprosthetic valves or rings) who successfully underwent transvenous, transseptal mitral valve replacement with a commercially available transcatheter heart valve. Results From April to May 2014, 4 consecutive patients underwent transvenous, transseptal mitral valve replacement with a transcatheter heart valve. The mean age was 72 ± 9.9 years, and the average Society of Thoracic Surgeons risk score was 12.5 ± 7.2%. All patients had severe, life-limiting dyspnea. The 4 procedures were successful without intra- or post-procedural complications; echocardiography indicated a well-seated and functioning mitral valve-in-valve or valve-in-ring. Patients were discharged within 2 days after valve replacement with marked improvement in dyspnea. Conclusions We describe an innovative technique of transcatheter mitral valve replacement. This case series demonstrates the feasibility of transcatheter mitral valve replacement using only femoral venous access, with a marked reduction in complications and length of hospital stay compared with transapical access or redo surgery.

KW - degenerative mitral prosthesis

KW - percutaneous mitral intervention

KW - percutaneous mitral repair

KW - transcatheter mitral valve replacement

KW - transcatheter valve-in-ring procedure

KW - transcatheter valve-in-valve procedure

UR - http://www.scopus.com/inward/record.url?scp=84929575189&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929575189&partnerID=8YFLogxK

U2 - 10.1016/j.jcin.2015.01.028

DO - 10.1016/j.jcin.2015.01.028

M3 - Article

C2 - 25999110

AN - SCOPUS:84929575189

VL - 8

SP - 850

EP - 857

JO - JACC: Cardiovascular Interventions

JF - JACC: Cardiovascular Interventions

SN - 1936-8798

IS - 6

ER -